Go To Content

Food and Drug Administration

News & Events

  • facebook
  • Google
  • Line
  • Twitter
  • Print(open a new window)

The international journal (JFDA) published by Food and Drug Administration, Taiwan, has reached the Impact Factor (IF) of 4.176. Citations, contributions and subscriptions are welcome.

【Update Date:2020-04-06unit:企劃及科技管理組

The Journal of Food and Drug Analysis (JFDA), published by the Food and Drug Administration, is currently the only international journal issued by a government unit of Taiwan that is listed in the Science Citation Index (SCI). It is also the only SCI journal on food science published in Taiwan. It is included in databases like Medline and PubMed by the United States National Library of Medicine (NLM), as an influential international journal. According to the Journal Citation Report of 2019, JFDA has reached the Impact Factor (IF) of 4.176 in 2018, ranking the 13th among SCI journals of food science worldwide (9.62%, in Q1 among 135), and ranking the 49th among SCI journals of pharmaceuticals (18.35%, in Q1 among 267). It also ranks the second (out of 39) among all the domestic SCI journals.

Starting in 1993, JFDA editors have been devoted to enhancing the quality of its articles so it maintains a recognized place in the field of food and drug research. It contains review articles and original articles in the fields of medicine, toxicology, food, medical devices, and cosmetics, focusing on the topics of food analysis, drug analysis, and chemical analysis. Articles on food health effects, analysis and evaluation of food microbes, pharmacokinetics, and Chinese herbal medicines are also featured in this journal. In addition, special issues are published with different themes every year. One of them is the "Benefits or Risks: The Interactions of Drugs with Herbs, Foods, Dietary Supplements and Adjuvants" in 2018, with the theme of the interaction between drugs and Chinese herbal medicine, food and nutritional supplement. Another is the "Special Issue of Mass Spectrometry for Clinical Diagnosis" published in 2019, which mainly introduces preclinical and clinical research through the use of modern mass spectrometry detection technology, and its recent advances in the field of medical research.

With its diverse content, JFDA authors are from 58 countries, including the United States, China, the United Kingdom, Australia, Poland, Italy, Spain, South Korea, Japan, Malaysia, and India. Scholars and experts from all over the world are most welcome to submit their research results to the journal to promote academic exchange among experts internationally. Please visit the JFDA website at http://www.fda.gov.tw/TC/publishJFDA.aspx for free full-text downloading.